TipRanks
Go Ultimate55% OFF

Sheryl Conley Insider Profile

11 Followers

Sheryl Conley, Director at Anika Therapeutics, holds 52.97K shares in Anika Therapeutics (Ticker: ANIK), holds 251.72K shares in Neuronetics (Ticker: STIM), holds 24.78K shares in Surgalign Holdings (Ticker: SRGAQ).

Sheryl Conley's Trading History

ANIK
Anika Therapeutics
Jun 23, 2026DirectorUninformative Buy―$1.11M
STIM
Neuronetics
May 29, 2026DirectorUninformative Buy―$566.36K
SRGAQ
Surgalign Holdings
Aug 17, 2022―Uninformative Buy―$446.09
ZBH
Zimmer Biomet Holdings
―Group Pres., Americas & Mktg.―$0.00

You May Also Like

Sheryl Conley insider profile FAQ

What is the percentage of profitable transactions made by Sheryl Conley?
The percentage of profitable transactions made by Sheryl Conley is 100%.
What is the average return per transaction made by Sheryl Conley?
The average return per transaction made by Sheryl Conley is 80.00%.
What stocks does Sheryl Conley hold?
Sheryl Conley holds: ANIK, SRGAQ, ZBH, STIM stocks.
What was Sheryl Conley's most profitable transaction?
Sheryl Conley’s most profitable transaction was an Informative Sell of STIM stock on June 1, 2021. The return on the trade was 80.70%.
What is Sheryl Conley's role in Anika Therapeutics?
Sheryl Conley's role in Anika Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.